Pharma is for sale although no one wants it



















Because ISTA is fighting for its own survival - latest is an ISTA acquisition by Valeant:

Valeant Pharmaceuticals Makes an Offer for ISTA Pharmaceuticals
The Offer: Valeant Pharmaceuticals (NYSE: VRX) offers $6.50 per share in cash to acquire ISTA Pharmaceuticals (NASDAQ: ISTA).
ISTA Pharmaceuticals' Board of Directors confirmed receipt of the Valeant offer and issued this statement:
The ISTA Board is committed to maximizing long-term shareholder value. Due to the fact that Valeant has attempted to revive its previously rejected proposal, ISTA's Board announced that it will commence a review of all strategic options available to ISTA in the context of its fiduciary responsibilities and the Company's strategic plans. ISTA also announced that it will be holding its 2012 Guidance and Pipeline Update webcast and call on January 4, 2012, during which it will discuss guidance for 2012, pipeline developments and key upcoming events.
ISTA Pharmaceuticals shares traded in a range of $5.93 to $6.95 Friday on 28 times the average daily volume.


Read more: http://www.benzinga.com/trading-ide...ter-for-friday-december-16-2011#ixzz1gvOiVLsE